Congress:
ECR25
Poster Number:
C-10066
Type:
Poster: EPOS Radiologist (scientific)
Authorblock:
M. C. Schlanke, M. Grözinger, M. Wennmann, S. Sauer, H-P. Schlemmer, S. Delorme, M-S. Raab, L. John, N. Weinhold; Heidelberg/DE
Disclosures:
Muriel Celine Schlanke:
Nothing to disclose
Martin Grözinger:
Nothing to disclose
Markus Wennmann:
Nothing to disclose
Sandra Sauer:
Nothing to disclose
Heinz-Peter Schlemmer:
Nothing to disclose
Stefan Delorme:
Nothing to disclose
Marc-Steffen Raab:
Nothing to disclose
Lukas John:
Nothing to disclose
Niels Weinhold:
Nothing to disclose
Keywords:
Bones, Haematologic, Oncology, MR, MR-Diffusion/Perfusion, Structured reporting, Cancer, Haematologic diseases, Lymphoma
Magnetic resonance imaging (MRI) is becoming increasingly important in the plasma cell malignancy multiple myeloma (MM). Recently, two structured reporting systems have been introduced to quantify the disease burden: the Myeloma Response Assessment and Diagnosis System (MY-RADS) [1] and the scoring system of Kim et al. (KIM-score) [2]. Here, we used these scores to systematically compare the disease distribution in newly diagnosed myeloma (NDMM) and relapsed/refractory myeloma (RRMM) and determined their prognostic impact in RRMM.